Last edition
News about "Eli Lilly obesity drug"
EMA Recommends Lilly's Foundayo for Weight Management
Eli Lilly’s Foundayo has received an EMA recommendation for marketing authorisation as an oral GLP-1 medicine for weight management and Type 2 Diabetes.
Eli Lilly Obesity Drug | 19/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members